Comprehensive transcriptome assessment in PBMCs of post-COVID patients at a median follow-up of 28 months after a mild COVID infection reveals upregulation of JAK/STAT signaling and a prolonged immune response
BackgroundPost-acute sequelae of SARS-CoV-2 infection (PASC), also known as post-COVID-19 condition (here abbreviated as post-COVID) is an escalating global health issue. The aim of our study was to investigate the mechanisms and clinical manifestations of post-COVID following a mild SARS-CoV-2 infe...
Saved in:
| Main Authors: | Serena Fineschi, Joakim Klar, Juan Ramon Lopez Egido, Jens Schuster, Jonas Bergquist, René Kaden, Niklas Dahl |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1589589/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
JAK/STAT signaling as a key regulator of ferroptosis: mechanisms and therapeutic potentials in cancer and diseases
by: Yimeng Dai, et al.
Published: (2025-03-01) -
JAK-STAT inhibitors in noninfectious uveitis – A review
by: Richa Pyare, et al.
Published: (2025-06-01) -
JAK inhibitors: a new choice for diabetes mellitus?
by: Mengjun Zhou, et al.
Published: (2025-01-01) -
Jak inhibitors in the treatment of alopecia areata - a literature review
by: Paulina Krzeszowska, et al.
Published: (2025-06-01) -
JAK-STAT Signaling in Autoimmunity and Cancer
by: Parveen S, et al.
Published: (2025-05-01)